CARLINA Technologies has currently 3 product candidates under development using its proprietary controlled drug delivery platforms:

  • PEPTIDOTS-Insulin : A prolonged-release form of insulin
  • SOLUDOTS-PTX : A tumor-targeted paclitaxel-loaded nanoparticle
  • SOLUGEL-DAP : A sustained-release form of daptomycin

Learn more about CARLINA Technologies